---- — Blood drives set
PLATTSBURGH — There are many opportunities to give blood in January through the North Country Regional Blood Donor Program.
Here’s the schedule: 9:30 a.m. to 2:30 p.m. today, Department of Environmental Conservation, Ray Brook; 4 to 7 p.m. today, Bangor Fire Department; noon to 5 p.m. Wednesday, Redfield Board Room, Adirondack Medical Center, Saranac Lake; 3 to 7 p.m. Thursday, Black Brook Town Hall; 9 a.m. to 2 p.m. Friday, Jan. 11, Saranac High School; 9 a.m. to noon Monday, Jan. 14, West Chazy Post Office; 3 to 6 p.m. Monday, Jan. 14, Keene Valley Neighborhood House; 11 a.m. to 2 p.m. Tuesday, Jan. 15, North Star Industries, Saranac Lake; 4 to 6 p.m. Tuesday, Jan. 15, Morrisonville Ambulance Service; noon to 3 p.m. Monday, Jan. 21, Garvey Hyundai, Tom Miller Road, Plattsburgh; 7 to 11 a.m. Tuesday, Jan. 22, NYSEG (includes bone-marrow registry); 12:30 to 5 p.m. Thursday, Jan. 24, Willsboro High School; 5 to 7 p.m. Thursday, Jan. 24, Eastern Adirondack Healthcare at Plattsburgh High School (includes bone-marrow registry); 10 a.m. to 4 p.m. Monday, Jan. 28, CVPH Auditorium A; 3 to 7 p.m. Tuesday, Jan. 29, Westport High School; 3:30 to 7 p.m. Tuesday, Jan. 29, Rouses Point Fire Department; 11 a.m. to 3 p.m. Wednesday, Jan. 30, Ticonderoga International Paper Mill; and noon to 3 p.m. Thursday, Jan. 31, North Country Regional Blood Center.
The Blood Donor Center, 85 Plaza Blvd., is open 8 a.m. to 6 p.m. Monday through Friday. Walk-in donors are encouraged. To learn how to host a drive, call 562-7406.
AMC offering Diabetes Self Management class
SARANAC LAKE — Adirondack Medical Center will offer its six-week comprehensive Diabetes Self Management Education Program starting Jan. 16.
Included in the sessions is valuable information on nutrition, exercise, medications and prevention of acute chronic complications.
The group, taught by an interdisciplinary team of four physicians, will meet on consecutive Wednesday evenings.
A physician referral is needed for insurance and Medicare or Medicaid coverage. Scholarships are available through the Adirondack Health Foundation. Call 897-2611 with questions or to register.
Fidelis Care Health Insurance Open House coming up
PLATTSBURGH — On Monday, Jan. 14, and Tuesday, Jan. 15, from 10 a.m. to 7 p.m., Fidelis Care will provide a free Health Insurance Open House in the lobby of CVPH Medical Center.
Representatives will provide information and answer questions to discuss options for low-cost or free coverage for those who qualify.
Fidelis offers New York state’s Child Health Plus, Family Health Plus and Medicaid Managed Care programs.
To apply for enrollment, bring proof of age, income and address.
Rehabilitation staff certified in new treatment technique
SARANAC LAKE — Twenty members of Adirondack Health’s Rehabilitation and Sports Science staff have received advanced certification to provide a unique treatment that targets physical movement limited by pain or injury-related soreness.
The rehabilitation staff recently participated in an advanced seminar to become skilled in the provision of Sound Assisted Soft Tissue Mobilization, also know as the “Graston Technique.” This method combines the hands-on care already provided by the therapists, with specialized instruments used to break down tissues that may be restricting certain movements. The sound-assisted soft-tissue treatment may help improve physical mobility for patients following surgery or who have suffered repeated strains, sprains and other injuries.
Adirondack Health’s Rehabilitation and Sports Science Department offers a free screening to help people with pain or injury-related soreness. Following a brief assessment, a qualified staff member will suggest the appropriate next steps for each individual situation. To learn more, call 897-2697.
Merck: FDA reviewing re-filed drug for surgery
WHITEHOUSE STATION, N.J. (AP) — Federal regulators are taking another look at Merck & Co.’s experimental drug for reversing effects of anesthesia after surgery, the drugmaker said Monday.
If approved, sugammadex would be the first in a new class of medicines in the United States for reversing effects of certain drugs that relax muscles during surgery.
This is Merck’s second attempt to get approval for the injected drug. The Food and Drug Administration rejected it in 2008 over concerns about allergic reactions and bleeding in some participants in clinical studies.
Merck, based in Whitehouse Station, N.J., later submitted additional information requested by the FDA. The company said it now expects the review to be completed in the first half of this year.
Sugammadex is one several drugs for which Merck plans to seek approval in 2013.